AKTS

NASDAQ · Equity

Aktis Oncology, Inc. Common stock

US Healthcare Biotechnology

Latest week
29 May 2026
Close
20.740000
Fair value
19.126000
Expectation
Undecided 48.04%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
20.74
12-Week Change
9.22%
Trend Signal
Inactive
Expectation
Undecided 48.04%
Signal Weeks
0 of 12
Vs Fair Value
Above
Market Dynamics
0.00

Over the latest 12 completed weeks ending 2026-05-29, AKTS rose 9.22%, moving from 18.99 to 20.74. The latest weekly close is above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Market Dynamics is 0.00 on the latest week. Expectation is undecided at 48.04%.